Mission
Vision
Why ELEM?
By safely testing new drugs and devices with unprecedented speed and scale, they generate fresh scientific evidence that supports product development and crucial business decisions.
Scientific Rigor
We actively advance biomedical research by publishing in peer-reviewed journals, presenting at leading conferences and contributing to global research collaborations.
Equity and access
Our Virtual Humans reduce reliance on animals, enable safe trials in rare and high-risk conditions, and create new opportunities for more inclusive and ethical studies.
Advanced
Our technology combines biomedical science, multiscale and multiphysics mechanistic modelling, AI, and supercomputer power.
Collaboration
Our PhD-level scientists and engineers partner with clinicians, therapeutic companies, and trial experts to replicate real-world studies and produce validated evidence.
Meticulous validation
Every result we deliver is backed by validated data, transparent versioning and rigorous scientific methodology
Founders & Board
Chris Morton
Founders & Board
Mariano Vázquez
Co-Founder
Guillaume Houzeaux
Co-Founder
José María Cela
Romain Micol, MD
Romain Micol, MD
Board Member
Jo Pisani
Board Member
Roger Assaker
Translational Systems Physiology
Tinen Iles, PhD
Cardiac Computational Modelling
Blanca Rodríguez, PhD
Cardiac Imaging and Function
Francesc Carreras Costa, MD
Senior Scientist
Jose María Guerra Ramos, MD
Electrophysiology, Arrhythmia
David Filgueiras Rama, MD
Otorhinolaryngology and Head and Neck Surgery
Cristóbal Langdon, MD
Translational Systems Physiology
Paul Iaizzo, MD
Signal and image processing
Oscar Camara, PhD